Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy

Journal of Infection

Volumn 53, Issue 2, 2006, Pages

  Intalapaporn, Poj ^a   Poovorawan, Yong ^b   Suankratay, Chusana ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Immune reconstitution syndrome; Parvovirus B19; Pure red cell aplasia and highly active antiretroviral therapy

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; PURE RED CELL ANEMIA; REAL TIME POLYMERASE CHAIN REACTION; SYMPTOM;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE;

EID: 33745853116     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.10.011     Document Type: Article

References (21)

1. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
2. Heegaard E.D., and Brown K.E. Human parvovirus B19. Clin Microbiol Rev 15 (2002) 485-505
3. Katta R. Parvovirus B19: a review. Dermatol Clin 20 (2002) 333-342
4. Zon L.I., and Groopman J.E. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 25 (1988) 208-218
5. van Elsacker-Niele A.M.W., Kroon F.P., van der Ende M.E., Salimans M.M., Spaan W.J., Kroes A.C., et al. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 23 (1996) 1255-1260
6. Chernak E., Dubin G., Henry D., Naides S.J., Hodinka R.L., MacGregor R.R., et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 20 (1995) 170-173
7. Shelburne III S.A., Hamill R.J., Rodriguez-Barradas M.C., Greenberg S.B., Atmar R.L., Musher D.W., et al. Immune reconstitution syndrome. Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81 (2002) 213-227
8. Hirsch H.H., Kaufmann G., Sendi P., and Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38 (2004) 1159-1166
9. French M.A., Mallal S.A., and Dawkins R.L. Zidovudine-induced restoration of cell-mediated immunity to mycobacterium in immunodeficient HIV-infected patients. AIDS 6 (1992) 1293-1297
10. Nolan R.C., Chidlow G., and French M.A. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection. Clin Infect Dis 36 (2003) 1191-1194
11. Charles R.J., Sabo K.M., Kidd P.G., and Abkowitz J.L. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 11 (1996) 4031-4038
12. Blanche P., Silberman B., Barreto L., Gombert B., and Sicard D. Reversible zidovudine-induced pure red cell aplasia. AIDS 13 (1999) 1586
13. Kreuzer K.A., and Rockstroh J.K. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 75 (1997) 179-187
14. Majluf-Cruz A., Luna-Castanos G., Trevino-Perez S., Santoscoy M., and Nieto-Cisneros L. Lamivudine-induced pure red cell aplasia. Am J Hematol 65 (2000) 189-191
15. Raguin G., Leruez-Ville M., Gregoire V., Deplanche M., Leport C., Morinet F., et al. Low prevalence of active parvovirus B19 infection in HIV-infected patients. Eur J Clin Microbiol Infect Dis 16 (1997) 760-762
16. Liu W., Ittmann M., Liu J., Schoentag R., Tierno P., Greco M.A., et al. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immuno-histochemistry. Hum Pathol 28 (1997) 760-766
17. Crook T.W., Rogers B.B., McFarland R.D., Kroft S.H., Muretto P., Hernandez J.A., et al. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Human Pathol 31 (2000) 161-168
18. Brown K.E. Detection and quantitation of parvovirus B19. J Clin Virol 31 (2004) 1-4
19. Young N.S. Parvovirus infection and its treatment. Clin Exp Immunol 104 Suppl. 1 (1996) 16-30
20. Koduri P.R., Kumapley R., Valladares J., and Teter C. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin - a report of eight patients. Am J Hematol 61 (1999) 16-20
21. Ramratnam B., Gollerkeri A., Schiffman F., Rintels P., and Flanigan T.P. Management of persistent B19 parvovirus infection in AIDS. Br J Hematol 91 (1995) 90-92